Effect of atorvastatin (80 mg) initiated at the time of coronary artery stent implantation on C-reactive protein and six-month clinical events

Am J Cardiol. 2002 Oct 1;90(7):786-9. doi: 10.1016/s0002-9149(02)02615-2.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon
  • Atorvastatin
  • C-Reactive Protein / metabolism*
  • Cholesterol / blood
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / drug therapy*
  • Coronary Artery Disease / mortality*
  • Coronary Artery Disease / therapy
  • Drug Administration Schedule
  • Female
  • Heptanoic Acids / administration & dosage*
  • Heptanoic Acids / blood
  • Humans
  • Incidence
  • Italy
  • Male
  • Middle Aged
  • Postoperative Care
  • Preoperative Care
  • Prospective Studies
  • Pyrroles / administration & dosage*
  • Pyrroles / blood
  • Stents
  • Survival Analysis
  • Time Factors
  • Treatment Outcome
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Heptanoic Acids
  • Pyrroles
  • Triglycerides
  • C-Reactive Protein
  • Cholesterol
  • Atorvastatin